A new study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast and skin.
Researchers flag similarities between COVID-19 deaths and severe rheumatic illnesses
Rheumatologists are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against the pandemic virus.
New drug combination being tested to conquer COVID-19
Researchers hope giving Remdesivir along with a powerful anti-inflammatory could be the key to treating the most severe COVID-19 cases.
More effective human antibodies possible with chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories. Researchers refer to their technique as the human ADLib system, short for autonomously diversifying libraries. The technique automatically builds vast…
Even natural products can be harmful for the unborn child
Plant products ingested by pregnant women through their diet are broken down by the intestinal microbiota into chemical substances, some of which can cross the placental barrier and reach the fetus. These foreign substances can harm the unborn child, e…
Study reveals first evidence inherited genetics can drive cancer’s spread
Scientists have long struggled to understand what drives a tumor to seed itself elsewhere in the body. New research implicates own pre-existing genetics.
First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response
A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.
Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms
A clinical trial in people with the new coronavirus is testing a drug that may halt an overactive immune response before it ramps up.
Immunity to coronaviruses: What do we know so far?
A new article discusses the existing knowledge about immune responses to SARS-CoV-2 and other coronaviruses, and how this could be used to inform virus control strategies.
A ‘switch’ that turns autoimmunity drugs into powerful anti-cancer treatments
Scientists have discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular ‘switch’.